Delhi Journal of Ophthalmology

Instruction to Authors

Our complete Author Guidelines are available at

We accept solicited and unsolicited manuscripts that are not under consideration for publication in any other journal. All submitted manuscripts are subject to review by independent experts in the field through an online reviewing system. You may submit your manuscripts along with a covering letter to Dr Kirti Singh (MD, DNB, FRCS, FAIMER, DHA), Editor-in-chief, Delhi Journal of Ophthalmology.

Manuscript Submission

All manuscripts are to be submitted online through the journal website: In case of any queries please contact the editorial office at the email address

Editorial Policy

Delhi Journal of Ophthalmology titles conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors (Updated December 2018,

Manuscript submission and processing

Delhi Journal of Ophthalmology publishes solicited and unsolicited articles. Acknowledgement of receipt of all manuscripts will be sent to the corresponding author, once the editorial desk reviews the manuscript for conforming to the requirements of the journal. The initial screening of the articles by the internal editorial staff assesses the topicality and importance of the subject, the clarity of presentation, formatting, and plagiarism.

We also have an active commissioning program whereby, under guidance from the Editorial Committee, we solicit articles directly for publication.

If you are interested in submitting an article, or have any queries regarding article submission, please contact the Editor-in-chief (see Contact details).

External review

In order to ensure that manuscript acceptance is unbiased, scientifically accurate and clinically relevant, all articles are reviewed by two or more members of the Editorial Committee and the Editorial Board and /or other specialists in the related fields. Review is performed on a double-blind basis, where in the identities of reviewers and authors are kept confidential. Reviewers must disclose potential conflicts of interests that may affect their ability to provide an unbiased appraisal (see Conflict of Interest Policy below).


Most manuscripts require some degree of revision prior to acceptance. Corresponding authors are requested to submit the revised manuscript along with one highlighted copy with revisions highlighted. Detailed responses to reviewers’ comments with point wise explanation to the reviewer’s comments are also required. The final decision on acceptance of the manuscript for publication lies with the Editor-in-chief.

Author disclosure, copyright transfer and conflict of interest policy

The corresponding author of the manuscript is responsible for obtaining permissions at the time of submission, to use material presented in the manuscript. Please send us a copy of letters or forms granting you permission for the use of copyrighted material in order to facilitate any special requirements with regard to wording and placement of credits that may be required. The corresponding author will be required to submit a signed copyright transfer form, signed by all co-authors, along with the manuscript at the time of submission, failing which the manuscript will not be considered for review. Copyright form is available online

Authors are responsible for the content of material and views expressed in the manuscripts. Authors must disclose explicitly conflict of interest (if any) and financial disclosure (or the lack of it) that may be relevant to the manuscript under consideration. This should figure at the end of the manuscript, before the “References” section.

Details of relevant conflicts of interests (or the lack of) must be declared in the ‘Disclosure’ section of the manuscript for all listed authors. Any such potential conflict of interest (including sources of funding) should be summarized in a separate section of the published article.

External reviewers must disclose any conflicts of interest that could bias their opinions of the manuscript, and they should disqualify themselves from reviewing specific manuscripts if they believe it to be appropriate. Should any such conflict of interest be declared, the journal Editor-in-chief will judge whether the reviewer’s comments should be recognized or will interpret the reviewer’s comments in the context of such declaration.

Policies on ethical conduct of research

Where manuscripts include publication of original data relating to human or animal experimental investigations, appropriate institutional review board approval is required and should be described within the article. For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. For investigations involving human subjects, authors should explain how informed consent was obtained from the participants involved. Identifying information should not be included unless the information is essential for scientific purposes and written informed consent is taken for publication. In attempting to maintain patient anonymity, identifying details should be omitted where they are not essential. However, patient data should never be amended or falsified. Informed consent should be obtained whenever there is any doubt that anonymity cannot be assured.

Manuscript Preparation

Details for manuscript preparation are as follows.

Manuscripts of the following types may be submitted:

Major Review: Manuscripts submitted in this section should be within 4000 words, with an unstructured abstract of up to 400 words.

Recent advances in diagnosis and therapeutics: Manuscripts submitted in this section should be within 4000 words, with an unstructured abstract of up to 400 words.

Original Article: Manuscripts submitted in this section should be within 2500 words with a structured abstract (purpose, methods, results, conclusion) of up to 250 words. The text should include an introduction, materials and methods, results and discussion section.

Allied Ophthalmic Sciences: Manuscripts submitted in this section should be within 3000 word limit with an unstructured abstract of up to 300 words. Submissions pertaining to research methodology, ocular pathology, ocular microbiology, ocular biochemistry, ocular pharmacology, ocular community medicine, ophthalmic hospital administration, optometry and contact lenses will be entertained.

Techniques: Videos of techniques in ophthalmology (video not longer than 8 minutes in MPEG 2 format) with title, credentials of presenting authors, disclosures, conflict of interest, acknowledgements and any other relevant details is to be included. The ophthalmic surgical technique is to be explicitly detailed in clear English narration. All relevant steps of surgery are to be lucidly described and depicted in the video. The video should be accompanied with manuscript of 1000 words (unstructured abstract, key words, text with subheading of introduction, surgical technique, discussion) and references. Visuals of hospitals of the corresponding authors etc are to be avoided in the video.

Case Reports: Interesting cases with immense clinical significance / rare case reports will be accepted in this category. Submissions in this category should include an unstructured abstract of up to 150 words with total text word limit of 1500 words. The text should include an introduction, case report and discussion.

Photo Essay: Submissions in this category should include high quality ophthalmic photography pertaining to an interesting rare case scenario or a case of teaching significance to ophthalmic postgraduate residents. The manuscript should be within 500 words, with a minimum of four figures and a maximum of five references. No abstract is required for this section. The text should include case details and comment. All figure legends should be clear and descriptive.

Brief Communications: Manuscripts in this category include short communication of original research or new laboratory technique related to vision sciences. The manuscript should be within 1000 words, with an unstructured abstract of 150 words.

Letter to Editor: Comments about an article published in the journal, or on topics of ophthalmic interest shall be considered. Comments regarding articles in the journal should be submitted within 3 months of publication, and the author(s) of that article will be given an opportunity to reply. Letters to the editor will be reviewed by the Editorial Board, may be subject to editing, and will be published as space and editorial priorities permit. These should not exceed 250 words of text and one figure or one table, and five references (including a reference to the journal article in question). Text should commence with “Dear Sir”.

New categories:

Instrument focus: Manuscripts submitted in this section should be within 1500 words with an unstructured abstract of up to 200 words.

Clinical challenge: This section should present a patient’s case details and relevant images with a clearly defined diagnostic or therapeutic dilemma. The case would be forwarded to one or more experts in the filed and their opinion solicited, with a final note by the section editor / editor. The manuscript should be within 800 words. No abstract or references are required.

PG snippet: High quality images depicting important clinical conditions / signs will be presented in a stimulating way in order to consolidate essential knowledge in Ophthalmology. This would be in a convenient “at a glance” format to enhance learning.

Formatting Requirements:

The manuscript is to be submitted as two files:

1. First page file: This should contain the covering letter, title page and signed authorship form. Please submit as word / pdf files. Do not zip the files. The title page should include:

  • Title of the manuscript
  • Type of manuscript
  • First name(s) and surnames of authors (see Authorship section below)
  • Author affiliations: Department, Institution, and contact details (mailing address, email and contact mobile number) of all authors
  • 3–6 keywords, Running title, Number of words of abstract and text (excluding references)
  • Corresponding author: name, designation and credentials, address, phone, email and digital passport size photograph

Criteria for authorship credit:

1. Substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data;
2. Drafting the article or revising it critically for important intellectual content; and
3. Final approval of the version to be published.

All contributors who do not meet the criteria for authorship (such as those who provided purely technical help, writing assistance, or a department chairperson who provided only general support) may be listed in the acknowledgments section.

2. Article file: This should contain the title, abstract, text, references, and figure legends. Figures and tables are to be submitted separately. No details regarding identity of authors should be included in this file.

Double-spacing of the entire text is to be done. The pages should be numbered. The preferred electronic format for text is Microsoft Word. Generic drug names are to be used in text, tables, and figures. Suppliers of drugs, equipment, and other brand-name material are to be credited in parentheses (company, name, city, state, country). Please spell out acronyms in the first instance of appearance in the abstract and paper.

Compliance with Ethical Requirements

For studies conducted with human subjects, statements pertaining to ethical standards should be included: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013. Informed consent was obtained from all patients for being included in the study. In the event of lack of clarity if the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.

For studies involving animal experiments, statements pertaining to ethics standards should be included: All institutional and national guidelines for the care and use of laboratory animals were followed.

If any identifying information about patients is included in the article, the following sentence should also be included: Additional informed consent was obtained from all patients for which identifying information is included in this article.

Figures and Tables are to be submitted as separate files. They are to be numbered in the sequence of appearance in the text, with a descriptive heading/legend provided for each. Abbreviations and footnotes are to be placed immediately below the table. Figures are to be submitted as JPEG, TIFF files, or in their originating graphics application. Graphics/contents downloaded from web pages are not acceptable.

References should be written in standard Vancouver format as follows: Authors. Title of citation quoted. Name of journal Year of publication; volume number: page numbers. ‘et al’ must be added after 6 author names.

Standard journal articles

• Bhalerao SA, Singh K, Yadav B, Kumar R. Isolated abscess in superior rectus muscle in a child. Indian J Ophthalmol 2015; 63: 284-6.


Personal author(s)

Bennet PN, Brown MJ. Clinical Pharmacology. Edinburgh: Churchill Livingstone; 2008. Psychotropic drugs; pp. 367–412.

Editor(s) or compiler(s) as authors

Beers MH, Porter RS, Jones TV, Kaplan JL, Berkwits M, editors. The Merck manual of diagnosis and therapy. 18th ed. Whitehouse Station (NJ): Merck Research Laboratories; 2006.

Authored chapter in edited publication

Meltzer H. Antipsychotic agents and lithium. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 10th ed. New York: McGraw-Hill; 2009. pp. 487–507.

Conference Abstracts

Author(s) of abstract.Title of abstract [abstract]. In: Name of conference or title of publication.; conference dates; place of conference.: publisher;. Abstract number.

Authors must disclose explicitly conflicts of interest, financial disclosures (or the lack of it), acknowledgements, that may be relevant to the manuscript under consideration. This should figure at the end of the manuscript, before the “References” section. The Conflict of Interest statement should list each author separately with regards to conflict of interest, research grants, speaker honorarium, financial interests etc. In case multiple authors declare no conflict, this may be stated separately for each author.

Please note: manuscripts will not be accepted for review if these instructions are not followed

The corresponding author will be responsible for any concerns regarding plagiarism or authorship related issues. The journal or the society will not be responsible for the views projected in the manuscripts.

Editorial Office

Dr. Kirti Singh

Editor–in–Chief, Delhi Journal of Ophthalmology

Dir Prof & Director GNEC, MAMC & Associated Hospital,
New Delhi State Progr. Officer, NPCB